financetom
Business
financetom
/
Business
/
Avery Dennison's Q4 Adjusted Earnings, Net Sales Increase
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Avery Dennison's Q4 Adjusted Earnings, Net Sales Increase
Jan 30, 2025 4:31 AM

07:10 AM EST, 01/30/2025 (MT Newswires) -- Avery Dennison (AVY) reported Q4 adjusted earnings Thursday of $2.38 per diluted share, up from $2.16 a year earlier.

Analysts polled by FactSet expected $2.38.

Net sales for the quarter ended Dec. 28 were $2.19 billion, compared with $2.11 billion a year earlier.

Analysts polled by FactSet expected $2.19 billion.

The company said it expects 2025 adjusted EPS of $9.80 to $10.20. Analysts polled by FactSet expect $10.43.

Shares of the company were down more than 4% in recent premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
New Jersey Resources Insider Sold Shares Worth $350,267, According to a Recent SEC Filing
New Jersey Resources Insider Sold Shares Worth $350,267, According to a Recent SEC Filing
Jun 14, 2024
04:47 PM EDT, 06/14/2024 (MT Newswires) -- Jane M Kenny, Director, on June 13, 2024, sold 8,300 shares in New Jersey Resources ( NJR ) for $350,267. Following the Form 4 filing with the SEC, Kenny has control over a total of 23,259 shares of the company, with 23,259 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/356309/000035630924000036/xslF345X03/wk-form4_1718397782.xml ...
Amgen Says FDA Approves Blincyto to Treat Type of Blood Cancer
Amgen Says FDA Approves Blincyto to Treat Type of Blood Cancer
Jun 14, 2024
04:43 PM EDT, 06/14/2024 (MT Newswires) -- Amgen ( AMGN ) said late Friday the US Food and Drug Administration has cleared Blincyto to treat adults and children one month or older with CD19-positive Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia, an aggressive type of blood cancer. The FDA approval, which is the third indication for Blincyto, covers people with...
--Claros Mortgage Trust Keeps Quarterly Dividend at $0.25 Per Share; Payable July 15 to Shareholders of Record June 28
--Claros Mortgage Trust Keeps Quarterly Dividend at $0.25 Per Share; Payable July 15 to Shareholders of Record June 28
Jun 14, 2024
04:43 PM EDT, 06/14/2024 (MT Newswires) -- Price: 8.09, Change: +0.01, Percent Change: +0.12 ...
Zurn Elkay Water Solutions Insider Sold Shares Worth $6,123,256, According to a Recent SEC Filing
Zurn Elkay Water Solutions Insider Sold Shares Worth $6,123,256, According to a Recent SEC Filing
Jun 14, 2024
04:35 PM EDT, 06/14/2024 (MT Newswires) -- April Jalazo, 10% Owner, on June 12, 2024, sold 194,081 shares in Zurn Elkay Water Solutions ( ZWS ) for $6,123,256. Following the Form 4 filing with the SEC, Jalazo has control over a total of 24,125,339 shares of the company, with 24,125,339 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1439288/000110465924071788/xslF345X03/tm2417331-2_4seq1.xml Price: 30.62, Change: +0.02, Percent...
Copyright 2023-2026 - www.financetom.com All Rights Reserved